Rvl Pharmaceuticals Plc
A specialty pharmaceutical company focused on eye care and medical aesthetics, best known for UPNEEQ, the first and only FDA-approved prescription eye drop that temporarily lifts droopy eyelids in adults. The company was formerly called Osmotica Pharmaceuticals and renamed itself RVL in 2022 to reflect its shift toward eye care. Its signature product traces back to an ophthalmologist who developed it after noticing his own mother's tired-looking eyes.
No financial data available for this security.